Ouabain decreases sarco(endo)plasmic reticulum calcium ATPase activity in rat hearts by a process involving protein oxidation

Am J Physiol Heart Circ Physiol. 2006 Dec;291(6):H3003-11. doi: 10.1152/ajpheart.00603.2006. Epub 2006 Jul 21.

Abstract

The effect of cardiac glycosides to increase cardiac inotropy by altering Ca(2+) cycling is well known but still poorly understood. The studies described in this report focus on defining the effects of ouabain signaling on sarcoplasmic reticulum Ca(2+)-ATPase function. Rat cardiac myocytes treated with 50 microM ouabain demonstrated substantial increases in systolic and diastolic Ca(2+) concentrations. The recovery time constant for the Ca(2+) transient, tau(Ca(2+)), was significantly prolonged by ouabain. Exposure to 10 microM H(2)O(2), which causes an increase in intracellular reactive oxygen species similar to that of 50 microM ouabain, caused a similar increase in tau(Ca(2+)). Concurrent exposure to 10 mM N-acetylcysteine or an aqueous extract from green tea (50 mg/ml) both prevented the increases in tau(Ca(2+)) as well as the changes in systolic or diastolic Ca(2+) concentrations. We also observed that 50 microM ouabain induced increases in developed pressure in addition to diastolic dysfunction in the isolated perfused rat heart. Coadministration of ouabain with N-acetylcysteine prevented these increases. Analysis of sarcoplasmic reticulum Ca(2+)-ATPase protein revealed increases in both the oxidation and nitrotyrosine content in the ouabain-treated hearts. Liquid chromatography-mass spectrometric analysis confirmed that the sarcoplasmic reticulum Ca(2+)-ATPase protein from ouabain-treated hearts had modifications consistent with oxidative and nitrosative stress. These data suggest that ouabain induces oxidative changes of the sarcoplasmic reticulum Ca(2+)-ATPase structure and function that may, in turn, produce some of the associated changes in Ca(2+) cycling and physiological function.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcysteine / pharmacology
  • Animals
  • Calcium / metabolism
  • Cells, Cultured
  • Enzyme Inhibitors / pharmacology*
  • Free Radical Scavengers / pharmacology
  • Gene Expression Regulation, Enzymologic / drug effects
  • Hydrogen Peroxide / pharmacology
  • Male
  • Myocardial Contraction / drug effects
  • Myocardial Contraction / physiology
  • Myocardium / cytology
  • Myocardium / enzymology*
  • Myocytes, Cardiac / cytology
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / enzymology
  • Myocytes, Cardiac / physiology
  • Ouabain / pharmacology*
  • Oxidants / pharmacology
  • Oxidation-Reduction / drug effects
  • Rats
  • Rats, Sprague-Dawley
  • Reactive Oxygen Species / metabolism
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases / chemistry
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases / drug effects*
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases / metabolism*

Substances

  • Enzyme Inhibitors
  • Free Radical Scavengers
  • Oxidants
  • Reactive Oxygen Species
  • Ouabain
  • Hydrogen Peroxide
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases
  • Calcium
  • Acetylcysteine